# Novartis confirms Sandoz spin-off for October 4, 2023
Published: 2023-09-25
Category: Headlines
Category URL: https://blockchaintribune.com/category/headlines/
Meta Title: Novartis Confirms Sandoz Spin-Off on October 4, 2023
Meta Description: Get the latest updates on Novartis' 100% spin-off of Sandoz business. Key regulatory approvals obtained. Stay informed with Novartis and Sandoz shares on S
Tags: h2
Tag URLs: h2 (https://blockchaintribune.com/tag/h2/)
URL: https://blockchaintribune.com/novartis-confirms-sandoz-spin-off-for-october-4-2023/

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qsvj8y0041wirgw17s2dn1/images/2023-09-25t052236z1lynxmpej8o04brtroptp4beigene-novartis-cancer-drug-1737056095509-compressed.jpg)

## Novartis confirms Sandoz spin-off for October 4, 2023   ZURICH (Reuters) – Novartis on Monday confirmed its plans for a 100% spin-off of the Sandoz business on Oct. 4 after shareholders gave their approval earlier this month.    Novartis also said key regulatory approvals have been obtained, including the [approval](https://blockchaintribune.com/spain-allows-blackrock-to-take-20-stake-in-naturgy-cinco-dias-reports/) by SIX Exchange Regulation for the listing of the Sandoz shares on the SIX Swiss Exchange.    The [Sandoz](https://blockchaintribune.com/novartis-to-spin-off-generics-business-sandoz-next-year/) shares will have the symbol SDZ, Novartis said.        (Reporting by John Revill, Editing by Rachel More)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---